Series B - Immune-Onc Therapeutics - Jan 5, 2023 Funding Round Profile - Cointime

Bitcoin $97,751.88 -1.56%
Ethereum $3,435.14 +4.70%
BNB $658.53 +6.05%
Optimism $2.24 +6.42%
Arbitrum $0.87 +13.58%
Solana $256.71 +1.51%
Polygon $0.58 +23.90%
Cosmos $8.28 +14.53%
Avalanche $42.25 +7.61%

Bitcoin $97,751.88 -1.56%
Ethereum $3,435.14 +4.70%
BNB $658.53 +6.05%
Optimism $2.24 +6.42%
Arbitrum $0.87 +13.58%
Solana $256.71 +1.51%
Polygon $0.58 +23.90%
Cosmos $8.28 +14.53%
Avalanche $42.25 +7.61%

Immune-Onc Therapeutics

company

Funding Round

Series B

Money Raised

$ 25M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Qianzhan Investment Management	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 1, 2016	Series A	$ 7M	Fame Mount Limited	Detail